Suchergebnisse - "Andrew Clark"

PubPharm (51)

1

Modification of Superabsorbent Polymer Granules and Fibers for Antimicrobial Efficacy and Malodor Control

in: ACS Omega | 2024

von Lori I. Robins | Luis Contreras | Andrew Clark | +5

2

Efficacy and safety of switching to dolutegravir/lamivudine in virologically suppressed people with HIV-1 aged ≥ 50 years: week 48 pooled results from the TANGO and SALSA studies

in: AIDS Research and Therapy | 2024

von Sharon Walmsley | Don E. Smith | Miguel Górgolas | +13

3

Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes

in: BMC Infectious Diseases | 2023

von Ricky K. Hsu | Jennifer S. Fusco | Cassidy E. Henegar | +6

4

ARAG, an Antioxidant-Rich Gel, Shows Superiority to Mepilex Ag in the Treatment of Deep Partial Thickness Burns without Sacrificing Antimicrobial Efficiency

in: Antioxidants | 2023

von Brian Michael Cartwright | Sean James Fox | Mary Jane Underdown | +2

5

Global mosquito observations dashboard (GMOD): creating a user-friendly web interface fueled by citizen science to monitor invasive and vector mosquitoes

in: International Journal of Health Geographics | 2023

von Johnny A. Uelmen | Andrew Clark | John Palmer | +5

6

P1388: EFFECTIVENESS AND SAFETY OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY (TABELECLEUCEL) UNDER AN EXPANDED ACCESS PROGRAM IN EUROPE

in: HemaSphere | 2023

von Sylvain Choquet | Andrew Clark | Cécile Renard | +11

7

A Multifaceted Approach to Developing an Australian National Map of Protected Cropping Structures

in: Land | 2023

von Andrew Clark | Craig Shephard | Andrew Robson | +3

8

Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study

in: BMC Health Services Research | 2023

von Joël Arthur Kiendrébéogo | Annick Raissa O. Sidibe | Ghislain Bertrand Compaoré | +6

9

Estimating the global impact of rotavirus vaccines on child mortality

in: International Journal of Infectious Diseases | 2023

von Andrew Clark | Sarwat Mahmud | Frederic Debellut | +8

10

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1

in: Infectious Diseases and Therapy | 2023

von Judith A. Aberg | Bronagh Shepherd | Marcia Wang | +13

1
2
3
4
5
6
Nächster »
[6]